Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging

Y Yao1,2, T D Nguyen2, S Pandya2

  • 1From the Department of Radiology (Y.Y., Y.Z.), Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.

Abstract

Insights

Chronic active multiple sclerosis (MS) lesions with a hyperintense rim show increased iron deposition and more myelin damage compared to lesions without a rim. This finding may help target therapies to reduce myelin damage in MS.

Area of Science:

  • Neuroimaging
  • Neuroinflammation
  • Biomarkers

Background:

  • Chronic active multiple sclerosis (MS) lesions often exhibit a hyperintense rim on susceptibility-weighted imaging, indicative of iron deposition.
  • Quantifying iron-related myelin damage in these specific lesions is crucial for understanding disease progression.

Purpose of the Study:

  • To quantify iron deposition and associated myelin damage in MS lesions with a hyperintense rim compared to those without.
  • To investigate the relationship between rim characteristics and myelin integrity over time.

Main Methods:

  • Longitudinal quantitative susceptibility mapping (QSM) was performed on 46 MS patients over approximately 29 months.
  • Myelin water fraction (MWF) mapping was used to assess myelin damage.
  • Mixed-effects models analyzed QSM and MWF values in rim-positive versus rim-negative lesions.

Main Results:

  • Rim-positive lesions showed significantly higher QSM values (indicating more iron) than rim-negative lesions.
  • Rim-positive lesions exhibited greater myelin damage, with lower MWF values compared to rim-negative lesions.
  • The volume of the rim at baseline negatively correlated with follow-up myelin water fraction, suggesting progressive damage.

Conclusions:

  • Hyperintense rim lesions in MS are associated with increased iron deposition and more significant myelin damage.
  • These findings support the identification of chronic active MS lesions and suggest potential therapeutic targets to mitigate myelin loss.